Skip to content
Riskpilot
← Back to search
Sign in
Get full access
Astimex Pharma Aktiebolag
AB
Active
Org 5566213780
Isafjordsgatan 36, 164 40
Kista
Wholesale of pharmaceutical and medical goods
· NACE 4646
Est. 2002
1-4 employees
Watchlist
Share
Sweden
/
Companies
/
Wholesale of pharmaceutical and medical goods
/
Astimex Pharma Aktiebolag
Overview
Financials
People & ownership
Related companies
Loading company…
People & ownership
Management
Actively employed in the business
Name
Role
Member since
Current (2)
NP
Nils Petter Nygren
Chief Auditor
Chief Auditor
2024
BS
Bengt Stefan Falck
Deputy Chief Executive Officer
Deputy Chief Executive Officer
2020
Former (1)
KE
Karl Erik Sture Larsson
Chief Auditor
Chief Auditor
2020 – 2024
Board of directors
Non-executive oversight
Name
Role
Member since
Current (2)
ÅB
Åsa Birgitta Lintzén
Chairman
2020
KB
Karin Birgitta Lintzén
Deputy Board Member
2020
Former (1)
NJ
Nils-Erik Jansson
Board of Directors
2020 – 2022
Shareholders
As of last annual report
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive.
Learn more
.
More on Astimex Pharma Aktiebolag
Overview →
Headline figures, risk assessment and company summary
Financials & key figures →
Revenue, EBITDA, balance sheet and 5-year trend
Related companies →
Corporate hierarchy, parent and subsidiary network
